PARK2 Co-Regulated (PACRG) Peptide
PACRG
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN938543
Quick Overview for PARK2 Co-Regulated (PACRG) Peptide (ABIN938543)
Target
PACRG
(PARK2 Co-Regulated (PACRG))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- GAIMARCNLD HLGSSDPPTS ASQVAEIIVN SGDGIDYSQQ KRENIGDLIQ
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PACRG antibody,
Alternative Names: PACRG control peptide, PACRG antibody Blocking Peptide, Anti-PACRG Blocking Peptide, Park2 Co-Regulated Blocking Peptide, FLJ32724 Blocking Peptide, GLUP Blocking Peptide, HAK005771 Blocking Peptide, PARK2CRG Blocking Peptide, RP3-495O10.2 Blocking Peptide -
Purification
- Purified
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- PACRG (PARK2 Co-Regulated (PACRG))
-
Background
- PACRG is a protein that is conserved across metazoans. In vertebrates, this gene is linked in a head-to-head arrangement with the adjacent parkin gene, which is associated with autosomal recessive juvenile Parkinson's disease. These genes are co-regulated in various tissues and they share a bi-directional promoter. Both genes are associated with susceptibility to leprosy.
-
Molecular Weight
- 33 kDa
Target
-
You are here:
